Lovastatin
Product Images NDC 53002-1385

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 53002-1385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

65abb8c3 847f 4fb3 B8de 21888c01210b 01

Chemical structure of the active ingredient lovastatin, showing its characteristic molecular framework including hydroxyl, carbonyl, and ester functional groups.*

FDA Label Image

65abb8c3 847f 4fb3 B8de 21888c01210b 02

A line graph titled 'Figure 1: Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over 6 years of follow-up comparing Lovastatin and Placebo groups. The graph indicates a 37% risk reduction with Lovastatin compared to Placebo (p<0.0001).*

FDA Label Image

Label Image (Lbl530021385)

Lovastatin 10mg tablets packaging label from RPK Pharmaceuticals, Inc. The label states 'Take 1 tablet daily or as directed' and shows a package count of 100 tablets. The label includes prescription-only designation, NDC 53002-1385-01, and instructions for use. Additional details include patient name placeholder, clinic name placeholder, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.